Friday, October 28, 2016

Sulpin




Sulpin may be available in the countries listed below.


Ingredient matches for Sulpin



Sulpiride

Sulpiride is reported as an ingredient of Sulpin in the following countries:


  • Taiwan

International Drug Name Search


Tuberculosis, Resistant Medications


Drugs associated with Tuberculosis, Resistant

The following drugs and medications are in some way related to, or used in the treatment of Tuberculosis, Resistant. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Utefos




Utefos may be available in the countries listed below.


Ingredient matches for Utefos



Tegafur

Tegafur is reported as an ingredient of Utefos in the following countries:


  • Spain

International Drug Name Search


Vina-H3




Vina-H3 may be available in the countries listed below.


Ingredient matches for Vina-H3



Procaine

Procaine hydrochloride (a derivative of Procaine) is reported as an ingredient of Vina-H3 in the following countries:


  • Vietnam

International Drug Name Search


Normolose-H




Normolose-H may be available in the countries listed below.


Ingredient matches for Normolose-H



Captopril

Captopril is reported as an ingredient of Normolose-H in the following countries:


  • Greece

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Normolose-H in the following countries:


  • Greece

International Drug Name Search


Thursday, October 27, 2016

Pamine


See also: Generic Pamine Forte


Pamine is a brand name of methscopolamine, approved by the FDA in the following formulation(s):


PAMINE (methscopolamine bromide - tablet; oral)



  • Manufacturer: FOUGERA PHARMS

    Approved Prior to Jan 1, 1982

    Strength(s): 2.5MG [RLD][AA]

Has a generic version of Pamine been approved?


Yes. The following products are equivalent to Pamine:


methscopolamine bromide tablet; oral



  • Manufacturer: BOCA PHARMA

    Approval date: December 28, 2006

    Strength(s): 2.5MG [AA]


  • Manufacturer: BRECKENRIDGE PHARM

    Approval date: December 6, 2011

    Strength(s): 2.5MG [AA]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Pamine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Pamine.

See also...

  • Pamine Consumer Information (Wolters Kluwer)
  • Pamine Consumer Information (Cerner Multum)
  • Pamine AHFS DI Monographs (ASHP)
  • Methscopolamine Consumer Information (Wolters Kluwer)
  • Methscopolamine Consumer Information (Cerner Multum)
  • Methscopolamine Bromide AHFS DI Monographs (ASHP)

Xopenex HFA


See also: Generic Xopenex


Xopenex HFA is a brand name of levalbuterol, approved by the FDA in the following formulation(s):


XOPENEX HFA (levalbuterol tartrate - aerosol, metered; inhalation)



  • Manufacturer: SUNOVION

    Approval date: March 11, 2005

    Strength(s): EQ 0.045MG BASE/INH [RLD]

Has a generic version of Xopenex HFA been approved?


No. There is currently no therapeutically equivalent version of Xopenex HFA available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xopenex HFA. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Method for treating asthma using optically pure (R)-albuterol
    Patent 5,362,755
    Issued: November 8, 1994
    Inventor(s): Barberich; Timothy J. & Young; James W.
    Assignee(s): Sepracor, Inc.
    The optically pure R(-) isomer of albuterol, which is substantially free of the S(+) isomer, is a potent bronchodilator for relieving the symptoms associated with asthma in individuals. A method is disclosed utilizing the optically pure R(-) isomer of albuterol for treating asthma while minimizing the side effects associated with chronic administration of racemic albuterol.
    Patent expiration dates:

    • March 25, 2013
      ✓ 
      Patent use: TREATMENT OR PREVENTION OF BRONCHOSPASM OR ASTHMATIC SYMPTOMS




  • Method for treating asthma using optically pure R(-) albuterol
    Patent 5,547,994
    Issued: August 20, 1996
    Inventor(s): Barberich; Timothy J. & Young; James W.
    Assignee(s): Sepracor, Inc.
    The optically pure R(-) isomer of albuterol, which is substantially free of the S(+) isomer, is a potent bronchodilator for relieving the symptoms associated with asthma in individuals. A method is disclosed utilizing the optically pure R(-) isomer of albuterol for treating asthma while minimizing the side effects associated with albuterol.
    Patent expiration dates:

    • August 20, 2013
      ✓ 
      Patent use: TREATMENT OR PREVENTION OF BRONCHOSPASM OR ASTHMATIC SYMPTOMS




  • Medicinal aerosol formulations
    Patent 5,605,674
    Issued: February 25, 1997
    Inventor(s): Purewal; Tarlochan S. & Greenleaf; David J.
    Assignee(s): Riker Laboratories, Inc.
    A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.
    Patent expiration dates:

    • February 25, 2014
      ✓ 
      Drug product




  • Seals for use in an aerosol delivery device
    Patent 5,836,299
    Issued: November 17, 1998
    Inventor(s): Kwon; Oh-Seung
    Assignee(s): Minnesota Mining & Manufacturing Co.
    A device for delivering an aerosol, comprising: a casing member, a valve stem, and a diaphragm. The diaphragm is made of an ethylene-propylene-diene rubber ("EPDM") and is stable to dimensional change when exposed to 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoroethane.
    Patent expiration dates:

    • November 17, 2015
      ✓ 
      Drug product




  • Levalbuterol salt
    Patent 7,256,310
    Issued: August 14, 2007
    Inventor(s): McGlynn; Paul & Bakale; Roger & Sturge; Craig
    Assignee(s): Sepracor Inc.
    Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
    Patent expiration dates:

    • October 8, 2024
      ✓ 
      Patent use: TREATMENT OR PREVENTION OF BRONCHOSPASM OR ASTHMATIC SYMPTOMS
      ✓ 
      Drug substance
      ✓ 
      Drug product



See also...

  • Xopenex HFA Aerosol Consumer Information (Wolters Kluwer)
  • Xopenex HFA Consumer Information (Cerner Multum)
  • Xopenex HFA Advanced Consumer Information (Micromedex)
  • Levalbuterol Aerosol Consumer Information (Wolters Kluwer)
  • Levalbuterol Solution Consumer Information (Wolters Kluwer)
  • Levalbuterol Consumer Information (Cerner Multum)
  • Xopenex Pediatric Advanced Consumer Information (Micromedex)
  • Levalbuterol Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
  • Levalbuterol AHFS DI Monographs (ASHP)

HCT AAA




HCT AAA may be available in the countries listed below.


Ingredient matches for HCT AAA



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of HCT AAA in the following countries:


  • Germany

International Drug Name Search


Opilet




Opilet may be available in the countries listed below.


Ingredient matches for Opilet



Azelaic Acid

Azelaic Acid is reported as an ingredient of Opilet in the following countries:


  • Greece

International Drug Name Search


Quinobiotic




Quinobiotic may be available in the countries listed below.


Ingredient matches for Quinobiotic



Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Quinobiotic in the following countries:


  • Peru

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Quinobiotic in the following countries:


  • Indonesia

International Drug Name Search


Digoxin KY




Digoxin KY may be available in the countries listed below.


Ingredient matches for Digoxin KY



Digoxin

Digoxin is reported as an ingredient of Digoxin KY in the following countries:


  • Japan

International Drug Name Search


Nautigo




Nautigo may be available in the countries listed below.


Ingredient matches for Nautigo



Domperidone

Domperidone is reported as an ingredient of Nautigo in the following countries:


  • India

International Drug Name Search


Zemplar


Zemplar is a brand name of paricalcitol, approved by the FDA in the following formulation(s):


ZEMPLAR (paricalcitol - capsule; oral)



  • Manufacturer: ABBOTT

    Approval date: May 26, 2005

    Strength(s): 1MCG, 2MCG, 4MCG [RLD]

ZEMPLAR (paricalcitol - injectable; injection)



  • Manufacturer: ABBOTT

    Approval date: April 17, 1998

    Strength(s): 0.005MG/ML [RLD][AP]


  • Manufacturer: ABBOTT

    Approval date: February 1, 2000

    Strength(s): 0.002MG/ML [RLD][AP]

Has a generic version of Zemplar been approved?


A generic version of Zemplar has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Zemplar and have been approved by the FDA:


paricalcitol injectable; injection



  • Manufacturer: SANDOZ CANADA INC

    Approval date: July 27, 2011

    Strength(s): 0.002MG/ML [AP], 0.005MG/ML [AP]

Note: No generic formulation of the following product is available.


  • paricalcitol - capsule; oral

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zemplar. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • 19-nor-vitamin D compounds for use in treating hyperparathyroidism
    Patent 5,246,925
    Issued: September 21, 1993
    Inventor(s): DeLuca; Hector F. & Schnoes; Heinrich K. & Perlman; Kato L. & Sicinski; Rafal R. & Prahl; Jean M.
    Assignee(s): Wisconsin Alumni Research Foundation
    This invention provides a novel class of vitamin D-related compounds, namely the 1.alpha.-hydroxy-19-nor-vitamin D analogs, as well as a general method for their chemical synthesis. The compounds exhibit pronounced activity in arresting the proliferation of undifferentiated cells, including malignant cells, and in inducing their differentiation, and thus represent novel therapeutic agents for the treatment of malignant and other diseases characterized by the proliferative growth of undifferentiated cells. Formulations for therapeutic use and treatment methods are also provided.
    Patent expiration dates:

    • April 17, 2012
      ✓ 
      Patent use: METHOD FOR TREATING HYPERPARATHYROIDISM WHICH COMPRISES SUPPRESSING PARATHYROID ACTIVITY


    • April 17, 2012
      ✓ 
      Patent use: PREVENTION AND TREATMENT OF SECONDARY HYPERPARATHYROIDISM ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) STAGE 3 AND 4


    • October 17, 2012
      ✓ 
      Pediatric exclusivity




  • 19-nor-vitamin D compounds
    Patent 5,587,497
    Issued: December 24, 1996
    Inventor(s): DeLuca; Hector F. & Schnoes; Heinrich K. & Perlman; Kato L. & Sicinski; Rafal R. & Prahl; Jean M.
    Assignee(s): Wisconsin Alumni Research Foundation
    This invention provides a novel class of vitamin D-related compounds, namely the 1.alpha.-hydroxy-19-nor-vitamin D analogs, as well as a general method for their chemical synthesis. The compounds exhibit pronounced activity in arresting the proliferation of undifferentiated cells, including malignant cells, and in inducing their differentiation, and thus represent novel therapeutic agents for the treatment of malignant and other diseases characterized by the proliferative growth of undifferentiated cells. Formulations for therapeutic use and treatment methods are also provided. The 19-nor vitamin D compounds have the formula: ##STR1## where X.sup.1 and X.sup.2 are each hydrogen or a hydroxy protecting group and R is a side chain.
    Patent expiration dates:

    • December 24, 2013


    • December 24, 2013
      ✓ 
      Drug substance


    • June 24, 2014
      ✓ 
      Pediatric exclusivity




  • Prevention of hyperphosphatemia in kidney disorder patients
    Patent 5,597,815
    Issued: January 28, 1997
    Inventor(s): Deluca; Hector F. & Slatopolsky; Eduardo
    Assignee(s): Wisconsin Alumni Research Foundation
    The 19-nor-vitamin D analogs, and particularly 19-nor-1.alpha.,25-dihydroxyvitamin D.sub.2, possess low calcemic and phosphatemic activity while also having the ability to suppress parathyroid hormone (PTH) production. The suppressive effect on PTH secretion of these 19-nor analogs without significant changes in serum calcium or serum phosphorus make them ideal tools for the treatment of secondary hyperparathyroidism in patients having kidney disorders.
    Patent expiration dates:

    • July 13, 2015
      ✓ 
      Patent use: PREVENTION AND TREATMENT OF SECONDARY HYPERPARATHYROIDISM ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) STAGE 5, WHICH MAY RESULT IN RENAL OSTEODYSTROPHY, WHILE AVOIDING HYPERPHOSPHATEMIA


    • January 13, 2016
      ✓ 
      Pediatric exclusivity




  • Cosolvent formulations
    Patent 6,136,799
    Issued: October 24, 2000
    Inventor(s): Li; Lukchiu & Pec; Edward Anthony & Robinson; Daniel H. & Stephens; Dennis A. & Jantzi; Kathee & May; Thomas Barton & Oberdier; John Paul
    Assignee(s): Abbott Laboratories
    Stable pharmaceutical formulations of a therapeutic agent, a low molecular weight alcohol and a glycol derivative are disclosed. Preferred formulations include 19-nor-1.alpha.,3.beta.,25-trihydroxy-9,10-secoergosta-5,7(E),22(E)-triene .
    Patent expiration dates:

    • April 8, 2018


    • October 8, 2018
      ✓ 
      Pediatric exclusivity




  • Cosolvent formulations
    Patent 6,361,758
    Issued: March 26, 2002
    Inventor(s): Lukchiu; Li & Edward Anthony; Pec & Daniel H.; Robinson & Dennis A.; Stephens & Kathee; Jantzi & Thomas Barton; May & John Paul; Oberdier
    Assignee(s): Abbott Laboratories
    Stable pharmaceutical formulations of a therapeutic agent, a low molecular weight alcohol and a glycol derivative are disclosed. Preferred formulations include 19-nor-1&agr;,3&bgr;,25-trihydroxy-9,10-secoergosta-5,7(E),22(E)-triene.
    Patent expiration dates:

    • April 8, 2018
      ✓ 
      Drug product


    • October 8, 2018
      ✓ 
      Pediatric exclusivity



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • June 29, 2012 - PREVENTION AND TREATMENT OF SECONDARY HYPERPARATHYROIDISM ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) STAGE 5 IN PATIENTS ON HEMODIALYSIS OR PERITONEAL DIALYSIS

See also...

  • Zemplar Consumer Information (Drugs.com)
  • Zemplar Consumer Information (Wolters Kluwer)
  • Zemplar Capsules Consumer Information (Wolters Kluwer)
  • Zemplar Consumer Information (Cerner Multum)
  • Zemplar Advanced Consumer Information (Micromedex)
  • Zemplar Intravenous Advanced Consumer Information (Micromedex)
  • Zemplar AHFS DI Monographs (ASHP)
  • Paricalcitol Consumer Information (Wolters Kluwer)
  • Paricalcitol Capsules Consumer Information (Wolters Kluwer)
  • Paricalcitol Consumer Information (Cerner Multum)
  • Paricalcitol Advanced Consumer Information (Micromedex)
  • Paricalcitol Intravenous Advanced Consumer Information (Micromedex)
  • Paricalcitol AHFS DI Monographs (ASHP)

Neotrin




Neotrin may be available in the countries listed below.


Ingredient matches for Neotrin



Metamizole

Metamizole sodium monohydrate (a derivative of Metamizole) is reported as an ingredient of Neotrin in the following countries:


  • Colombia

International Drug Name Search


D-Cough




D-Cough may be available in the countries listed below.


Ingredient matches for D-Cough



Dextromethorphan

Dextromethorphan is reported as an ingredient of D-Cough in the following countries:


  • Bangladesh

International Drug Name Search


Wednesday, October 26, 2016

Nufadex




Nufadex may be available in the countries listed below.


Ingredient matches for Nufadex



Dexamethasone

Dexamethasone is reported as an ingredient of Nufadex in the following countries:


  • Indonesia

International Drug Name Search


Sodium Monofluorophosphate




Scheme

USP

ATC (Anatomical Therapeutic Chemical Classification)

A01AA02,A12CD02

CAS registry number (Chemical Abstracts Service)

0010163-15-2

Chemical Formula

F-Na2-O3-P

Molecular Weight

143

Therapeutic Categories

Mineral supplement

Prophylactic: Dental caries

Chemical Name

Phosphorofluoridic acid, disodium salt

Foreign Names

  • Natrium fluorophosphat (German)
  • Monofluorophosphate de sodium (French)

Generic Names

  • Sodium (monofluorophosphate de) (OS: DCF)
  • Disodium phosphorofluoridate (IS)
  • MFP Sodium (IS)
  • Natrii monofluorophosphas (IS)
  • Sodium Fluorophosphate (IS)
  • Sodium Monofluorophosphate (PH: USP 32)

Brand Names

  • Fluocaril bi-fluoré (Sodium Monofluorophosphate and Sodium Fluoride)
    Procter & Gamble, Italy; Sanofi-aventis, Greece; Procter & Gamble, France

International Drug Name Search

Glossary

DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
USPPharmacopoeia of the United States

Click for further information on drug naming conventions and International Nonproprietary Names.

Zolpidem AL




Zolpidem AL may be available in the countries listed below.


Ingredient matches for Zolpidem AL



Zolpidem

Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Zolpidem AL in the following countries:


  • Germany

  • Romania

International Drug Name Search


Opeaspirin




Opeaspirin may be available in the countries listed below.


Ingredient matches for Opeaspirin



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Opeaspirin in the following countries:


  • Vietnam

International Drug Name Search


Diltiazem Siga




Diltiazem Siga may be available in the countries listed below.


Ingredient matches for Diltiazem Siga



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Diltiazem Siga in the following countries:


  • Germany

International Drug Name Search


Zantac


See also: Generic Zantac 150, Generic Zantac 300


Zantac is a brand name of ranitidine, approved by the FDA in the following formulation(s):


ZANTAC (ranitidine hydrochloride - injectable; injection)



  • Manufacturer: GLAXOSMITHKLINE

    Approval date: October 19, 1984

    Strength(s): EQ 25MG BASE/ML [RLD][AP]

ZANTAC (ranitidine hydrochloride - syrup; oral)



  • Manufacturer: GLAXOSMITHKLINE

    Approval date: December 30, 1988

    Strength(s): EQ 15MG BASE/ML [RLD][AA]

Has a generic version of Zantac been approved?


Yes. The following products are equivalent to Zantac:


ranitidine hydrochloride injectable; injection



  • Manufacturer: BEDFORD

    Approval date: February 16, 2006

    Strength(s): EQ 25MG BASE/ML [AP]


  • Manufacturer: BEN VENUE

    Approval date: March 2, 2005

    Strength(s): EQ 25MG BASE/ML [AP]

ranitidine hydrochloride syrup; oral



  • Manufacturer: ACTAVIS MID ATLANTIC

    Approval date: February 21, 2007

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: AMNEAL PHARMS

    Approval date: September 2, 2008

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: APOTEX

    Approval date: September 17, 2007

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: AUROBINDO PHARM

    Approval date: July 28, 2010

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: CYPRESS PHARM

    Approval date: August 27, 2009

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: DR REDDYS LABS LTD

    Approval date: May 26, 2009

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: HI TECH PHARMA

    Approval date: March 22, 2011

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: PHARM ASSOC

    Approval date: September 21, 2007

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: RANBAXY

    Approval date: December 13, 2007

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: SILARX

    Approval date: December 9, 2010

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: SUN PHARM INDS INC

    Approval date: September 20, 2011

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: TARO

    Approval date: June 13, 2011

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: TOLMAR

    Approval date: November 15, 2010

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: VINTAGE PHARMS

    Approval date: July 1, 2010

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: WOCKHARDT

    Approval date: February 23, 2009

    Strength(s): EQ 15MG BASE/ML [AA]


  • Manufacturer: WOCKHARDT

    Approval date: May 26, 2009

    Strength(s): EQ 15MG BASE/ML [AA]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zantac. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Zantac.

See also...

  • Zantac Consumer Information (Drugs.com)
  • Zantac Consumer Information (Wolters Kluwer)
  • Zantac Syrup Consumer Information (Wolters Kluwer)
  • Zantac Tablets Consumer Information (Wolters Kluwer)
  • Zantac Consumer Information (Cerner Multum)
  • Zantac AHFS DI Monographs (ASHP)
  • Ranitidine Consumer Information (Drugs.com)
  • Ranitidine Consumer Information (Wolters Kluwer)
  • Ranitidine Effervescent Tablets Consumer Information (Wolters Kluwer)
  • Ranitidine Syrup Consumer Information (Wolters Kluwer)
  • Ranitidine Tablets Consumer Information (Wolters Kluwer)
  • Ranitidine Consumer Information (Cerner Multum)
  • Ranitidine Hydrochloride AHFS DI Monographs (ASHP)

Octotiamine




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000137-86-0

Chemical Formula

C23-H36-N4-O5-S3

Molecular Weight

544

Therapeutic Category

Vitamin B₁

Chemical Name

Octanoic acid, 6-(acetylthio)-8-[[2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl]formylamino]-1-(2-hydroxyethyl)-1-propenyl]dithio]-, methyl ester

Foreign Names

  • Octotiaminum (Latin)
  • Octotiamin (German)
  • Octotiamine (French)
  • Octotiamina (Spanish)

Generic Names

  • Octotiamine (OS: JAN)
  • TATD (IS)

Brand Names

  • Neuvita
    Astellas, Japan; I'rom SeiyakuAiromu, Japan

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Natildine




Natildine may be available in the countries listed below.


Ingredient matches for Natildine



Midodrine

Midodrine hydrochloride (a derivative of Midodrine) is reported as an ingredient of Natildine in the following countries:


  • Japan

International Drug Name Search


Vasotenal




Vasotenal may be available in the countries listed below.


Ingredient matches for Vasotenal



Simvastatin

Simvastatin is reported as an ingredient of Vasotenal in the following countries:


  • Argentina

  • Chile

  • Peru

  • Venezuela

International Drug Name Search


Neomedil




Neomedil may be available in the countries listed below.


Ingredient matches for Neomedil



Benzalkonium Chloride

Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Neomedil in the following countries:


  • Italy

International Drug Name Search


Tuesday, October 25, 2016

Dopamina




Dopamina may be available in the countries listed below.


Ingredient matches for Dopamina



Dopamine

Dopamina (DCIT) is known as Dopamine in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Hypertensive Heart without CHF and Renal Disease Medications


There are currently no drugs listed for "Hypertensive Heart without CHF and Renal Disease".

Learn more about Hypertensive Heart without CHF and Renal Disease





Drug List:


Dolospam Lch




Dolospam Lch may be available in the countries listed below.


Ingredient matches for Dolospam Lch



Atropine

Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Dolospam Lch in the following countries:


  • Peru

International Drug Name Search


Antituberculosis agents


Antituberculosis agents are drugs used to treat tuberculosis, an infectious disease caused by Mycobacterium tuberculosis. This infection mainly affects the lungs but can also affect many other organ systems. Many classes of drugs, with different mechanism of action have activity against Mycobacterium tuberculosis.


Tuberculosis chemotherapy involves giving two to four drugs simultaneously. These drugs work differently so they target the organism in different ways and using a few types of drugs prevents drug resistant strains of Mycobacterium from evolving.

See also

  • aminosalicylates
  • antituberculosis combinations
  • miscellaneous antituberculosis agents
  • nicotinic acid derivatives
  • rifamycin derivatives
  • streptomyces derivatives

Drug List:


Zamadol




In the US, Zamadol is a member of the drug class miscellaneous analgesics and is used to treat Back Pain, Fibromyalgia, Pain, Restless Legs Syndrome and Rheumatoid Arthritis.

UK matches:

  • ZAMADOL 24hr 150 (200/300/400)mg TABLETS
  • Zamadol capsules 50mg
  • Zamadol Injection
  • Zamadol Melt 50mg Tablets
  • Zamadol SR Capsules 50mg, 100mg, 150mg, 200mg
  • ZAMADOL 24hr 150 (200/300/400)mg TABLETS (SPC)
  • Zamadol Capsules 50 mg (SPC)
  • Zamadol Injection (SPC)
  • Zamadol Melt 50 mg Tablets (SPC)
  • Zamadol SR Capsules 50mg, 100mg, 150mg, 200mg (SPC)

Ingredient matches for Zamadol



Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Zamadol in the following countries:


  • Ireland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Optiray 300


See also: Generic Optiray 240, Generic Optiray 320, Generic Optiray 350


Optiray 300 is a brand name of ioversol, approved by the FDA in the following formulation(s):


OPTIRAY 300 (ioversol - injectable; injection)



  • Manufacturer: MALLINCKRODT

    Approval date: January 22, 1992

    Strength(s): 64% [RLD]


  • Manufacturer: MALLINCKRODT

    Approval date: May 13, 1999

    Strength(s): 64% [RLD]

Has a generic version of Optiray 300 been approved?


No. There is currently no therapeutically equivalent version of Optiray 300 available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Optiray 300. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Optiray 300.

See also...

  • Optiray 300 Consumer Information (Cerner Multum)
  • Ioversol Consumer Information (Cerner Multum)

Monday, October 24, 2016

Solu-Dacortin




Solu-Dacortin may be available in the countries listed below.


Ingredient matches for Solu-Dacortin



Prednisolone

Prednisolone 21-(sodium succinate) (a derivative of Prednisolone) is reported as an ingredient of Solu-Dacortin in the following countries:


  • Austria

  • Luxembourg

International Drug Name Search


Zel




Ingredient matches for Zel



Selegiline

Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Zel in the following countries:


  • United States

International Drug Name Search


Dipirona Ecar




Dipirona Ecar may be available in the countries listed below.


Ingredient matches for Dipirona Ecar



Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Dipirona Ecar in the following countries:


  • Colombia

International Drug Name Search


Norten




Norten may be available in the countries listed below.


Ingredient matches for Norten



Imidapril

Imidapril hydrochloride (a derivative of Imidapril) is reported as an ingredient of Norten in the following countries:


  • Philippines

International Drug Name Search


Delspart




Delspart may be available in the countries listed below.


Ingredient matches for Delspart



Clobetasol

Clobetasol 17α-propionate (a derivative of Clobetasol) is reported as an ingredient of Delspart in the following countries:


  • Japan

International Drug Name Search


Sunday, October 23, 2016

Oruru




Oruru may be available in the countries listed below.


Ingredient matches for Oruru



Oryzanol

Oryzanol is reported as an ingredient of Oruru in the following countries:


  • Japan

International Drug Name Search


Angiocardiography Medications


Topics under Angiocardiography

  • Pediatric Angiocardiography (5 drugs)





Drug List:


NicoDerm CQ




In the US, NicoDerm CQ (nicotine systemic) is a member of the drug class smoking cessation agents and is used to treat Smoking Cessation.

US matches:

  • Nicoderm CQ Patch

  • Nicoderm CQ

Ingredient matches for NicoDerm CQ



Nicotine

Nicotine is reported as an ingredient of NicoDerm CQ in the following countries:


  • United States

International Drug Name Search


Oxazepam




In the US, Oxazepam (oxazepam systemic) is a member of the drug class benzodiazepines and is used to treat Alcohol Withdrawal and Anxiety.

US matches:

  • Oxazepam

UK matches:

  • Oxazepam Tablets 10mg, 15mg (Actavis UK Ltd)
  • Oxazepam Tablets BP 10mg (SPC)
  • Oxazepam Tablets BP 15mg (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05BA04

CAS registry number (Chemical Abstracts Service)

0000604-75-1

Chemical Formula

C15-H11-Cl-N2-O2

Molecular Weight

286

Therapeutic Categories

Anxiolytic agent

Benzodiazepine derivative

Hypnotic agent

Treatment of alcohol withdrawal symptoms

Chemical Name

2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-

Foreign Names

  • Oxazepamum (Latin)
  • Oxazepam (German)
  • Oxazépam (French)
  • Oxazepam (Spanish)

Generic Names

  • Oxazepam (OS: BAN, DCIT, JAN, USAN)
  • Oxazépam (OS: DCF)
  • CB 8092 (IS)
  • Wy 3498 (IS)
  • Oxazepam (PH: BP 2010, USP 32, Ph. Eur. 6)
  • Oxazépam (PH: Ph. Eur. 6)
  • Oxazepamum (PH: Ph. Eur. 6)

Brand Names

  • Adumbran
    Boehringer Ingelheim, Austria; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Ethiopia


  • Alepam
    Alphapharm, Australia; Alphapharm, Taiwan


  • Alopam
    Actavis, Denmark; Actavis, Norway


  • Anxiolit plus (Oxazepam and Benactyzin)
    Gerot, Austria


  • Anxiolit
    Gerot, Austria; Vifor, Switzerland


  • Apo-Oxazepam
    Apotex, Canada


  • Durazepam
    Mylan dura, Germany


  • Limbial
    Chiesi, Italy


  • Murelax
    Fawns & McAllan, Australia


  • Nozepam
    Olainfarm, Lithuania; Olainfarm, Latvia


  • Oksazepam
    Belupo, Croatia (Hrvatska); Belupo, Slovenia; Polfa Tarchomin, Poland


  • Opamox
    Orion, Finland


  • Oxabenz
    Actavis, Denmark


  • Oxa-CT
    CT Arzneimittel, Germany


  • Oxam
    Genexo, Poland


  • Oxamin
    Ratiopharm, Finland


  • Oxapax
    Sandoz, Denmark


  • Oxascand
    Teva, Sweden


  • Oxazepam A
    Apothecon, Netherlands


  • Oxazepam Accordhealthcare
    Accord Healthcare, Netherlands


  • Oxazepam Actavis
    Actavis, Estonia; Actavis, Netherlands


  • Oxazepam AL
    Aliud, Germany


  • Oxazepam CF
    Centrafarm, Netherlands


  • Oxazepam EB
    Eurobase, Netherlands


  • Oxazepam EG
    Eurogenerics, Belgium


  • Oxazepam FLX
    Karib, Netherlands


  • Oxazepam GenRx
    GenRx, Netherlands


  • Oxazepam Hexal
    Hexal, Germany


  • Oxazepam Katwijk
    Apotex Europe, Netherlands


  • Oxazepam Leciva
    Zentiva, Czech Republic; Zentiva, Slovakia


  • Oxazepam Merck
    Mylan, Netherlands


  • Oxazepam PCH
    Pharmachemie, Netherlands


  • Oxazepam ratiopharm
    ratiopharm, Netherlands


  • Oxazepam SAD
    Amgros, Denmark


  • Oxazepam Sandoz
    Sandoz, Germany; Sandoz, Netherlands


  • Oxazepam Stada
    Stada, Germany


  • Oxazepam TAD
    TAD, Germany


  • Oxazepam
    Actavis, United States; GlaxoSmithKline, Poland; Sandoz, United States; Teva USA, United States; Watson, United States


  • Oxazepam-1A Pharma
    1A Pharma, Germany


  • Oxazepam-Eurogenerics
    Eurogenerics, Luxembourg


  • Oxazepam-neuraxpharm
    Neuraxpharm, Germany


  • Oxazepam-ratiopharm
    Ratiopharm, Germany; Ratiopharm, Luxembourg


  • Ox-Pam
    Douglas, New Zealand


  • Praxiten
    Meda, Austria; Pliva, Bosnia & Herzegowina; Pliva, Croatia (Hrvatska); Pliva, Slovenia; Teofarma, Germany


  • Purata
    Aspen Pharmacare, South Africa


  • Sandoz Oxazepam
    Sandoz, South Africa


  • Serenal
    Wyeth, Portugal


  • Serepax
    Akromed, South Africa; Sigma, Australia; Wyeth, Chile; Wyeth, India


  • Seresta
    EuroCept, Netherlands; Meda, Belgium; Meda, Switzerland; Wyeth, Luxembourg


  • Séresta
    Biodim, France


  • Serpax
    Wyeth Medica Ireland-EIR, Italy


  • Sobril
    Pfizer, Iceland; Pfizer, Norway; Pfizer, Sweden


  • Tazepam
    Polfa Tarchomin, Georgia; Polfa Tarchomin, Lithuania; Polfa Tarchomin, Latvia; Polfa Tarchomin, Russian Federation


  • Tranquo
    Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Luxembourg


  • Vaben
    Rafa, Israel


  • Youfei
    Yimin, China

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Hypoactive Sexual Desire Disorder Medications


There are currently no drugs listed for "Hypoactive Sexual Desire Disorder". See Sexual Disorders.

Definition of Hypoactive Sexual Desire Disorder: Hypoactive Sexual Desire Disorder (HSDD) is a deficiency or absence of sexual fantasies and desire for sexual activity. This is considered a disorder if it causes distress for the patient or problems in the patient's relationships.





Drug List:


Nasivion




Nasivion may be available in the countries listed below.


Ingredient matches for Nasivion



Oxymetazoline

Oxymetazoline hydrochloride (a derivative of Oxymetazoline) is reported as an ingredient of Nasivion in the following countries:


  • India

  • Sri Lanka

International Drug Name Search


Opthavir




Opthavir may be available in the countries listed below.


Ingredient matches for Opthavir



Acyclovir

Aciclovir is reported as an ingredient of Opthavir in the following countries:


  • Mexico

International Drug Name Search


Daritmin




Daritmin may be available in the countries listed below.


Ingredient matches for Daritmin



Amiodarone

Amiodarone hydrochloride (a derivative of Amiodarone) is reported as an ingredient of Daritmin in the following countries:


  • Romania

International Drug Name Search


Viartril




Viartril may be available in the countries listed below.


Ingredient matches for Viartril



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Viartril in the following countries:


  • Argentina

Glucosamine

Glucosamine sulfate (a derivative of Glucosamine) is reported as an ingredient of Viartril in the following countries:


  • Bolivia

  • Chile

  • Colombia

  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Haiti

  • Honduras

  • Malaysia

  • Panama

  • Philippines

  • Portugal

  • Singapore

  • Thailand

International Drug Name Search


Diamitus




Diamitus may be available in the countries listed below.


Ingredient matches for Diamitus



Glimepiride

Glimepiride is reported as an ingredient of Diamitus in the following countries:


  • Hungary

International Drug Name Search


Dexipharm




Dexipharm may be available in the countries listed below.


Ingredient matches for Dexipharm



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Dexipharm in the following countries:


  • Vietnam

International Drug Name Search


Dolo-Quimagesico




Dolo-Quimagesico may be available in the countries listed below.


Ingredient matches for Dolo-Quimagesico



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Dolo-Quimagesico in the following countries:


  • Peru

International Drug Name Search


Saturday, October 22, 2016

Sharizol




Sharizol may be available in the countries listed below.


Ingredient matches for Sharizol



Metronidazole

Metronidazole is reported as an ingredient of Sharizol in the following countries:


  • Iraq

  • Yemen

International Drug Name Search


Vetalog




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vetalog



Triamcinolone

Triamcinolone 16α,17α-acetonide (a derivative of Triamcinolone) is reported as an ingredient of Vetalog in the following countries:


  • United States

International Drug Name Search


Dalmapam




Dalmapam may be available in the countries listed below.


Ingredient matches for Dalmapam



Flurazepam

Flurazepam monohydrochloride (a derivative of Flurazepam) is reported as an ingredient of Dalmapam in the following countries:


  • Ireland

International Drug Name Search


Utinor




Utinor may be available in the countries listed below.


UK matches:

  • Utinor 400mg Tablets
  • Utinor Tablets 400mg (SPC)

Ingredient matches for Utinor



Norfloxacin

Norfloxacin is reported as an ingredient of Utinor in the following countries:


  • Italy

  • Malta

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, October 21, 2016

Weimok




Weimok may be available in the countries listed below.


Ingredient matches for Weimok



Famotidine

Famotidine is reported as an ingredient of Weimok in the following countries:


  • Taiwan

International Drug Name Search


Dissen




Dissen may be available in the countries listed below.


Ingredient matches for Dissen



Loratadine

Loratadine is reported as an ingredient of Dissen in the following countries:


  • Mexico

International Drug Name Search


Milk Ejection Medications


There are currently no drugs listed for "Milk Ejection".

Definition of Milk Ejection: Reflex in which tactile stimulation of nipples causes release of oxytocin which causes myoepithelial cells surrounding mammary alveoli to contract and expel the milk. Applies to humans and animals.





Drug List:


Nimulid




Nimulid may be available in the countries listed below.


Ingredient matches for Nimulid



Nimesulide

Nimesulide is reported as an ingredient of Nimulid in the following countries:


  • India

  • Serbia

International Drug Name Search


Urocarb




Urocarb may be available in the countries listed below.


Ingredient matches for Urocarb



Bethanechol

Bethanechol Chloride is reported as an ingredient of Urocarb in the following countries:


  • Australia

International Drug Name Search


Spironolacton Lindopharm




Spironolacton Lindopharm may be available in the countries listed below.


Ingredient matches for Spironolacton Lindopharm



Spironolactone

Spironolactone is reported as an ingredient of Spironolacton Lindopharm in the following countries:


  • Germany

International Drug Name Search


Thursday, October 20, 2016

Sedaquin




Sedaquin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sedaquin



Acepromazine

Acepromazine maleate (a derivative of Acepromazine) is reported as an ingredient of Sedaquin in the following countries:


  • Australia

International Drug Name Search


Serelose




Serelose may be available in the countries listed below.


Ingredient matches for Serelose



Lactulose

Lactulose is reported as an ingredient of Serelose in the following countries:


  • Bangladesh

International Drug Name Search


Zopiratio




Zopiratio may be available in the countries listed below.


Ingredient matches for Zopiratio



Eszopiclone

Zopiclone is reported as an ingredient of Zopiratio in the following countries:


  • Poland

International Drug Name Search


Oralipin




Oralipin may be available in the countries listed below.


Ingredient matches for Oralipin



Bezafibrate

Bezafibrate is reported as an ingredient of Oralipin in the following countries:


  • Chile

International Drug Name Search


Silegon




Silegon may be available in the countries listed below.


Ingredient matches for Silegon



Silibinin

Silibinin is reported as an ingredient of Silegon in the following countries:


  • Hungary

International Drug Name Search


Scopas




Scopas may be available in the countries listed below.


Ingredient matches for Scopas



Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Scopas in the following countries:


  • Thailand

International Drug Name Search


Domped




Domped may be available in the countries listed below.


Ingredient matches for Domped



Domperidone

Domperidone is reported as an ingredient of Domped in the following countries:


  • India

Pantoprazole

Pantoprazole is reported as an ingredient of Domped in the following countries:


  • India

International Drug Name Search


Oftalmolosa Cusi Eritromicina




Oftalmolosa Cusi Eritromicina may be available in the countries listed below.


Ingredient matches for Oftalmolosa Cusi Eritromicina



Erythromycin

Erythromycin is reported as an ingredient of Oftalmolosa Cusi Eritromicina in the following countries:


  • Spain

International Drug Name Search


Wednesday, October 19, 2016

Weiliufen




Weiliufen may be available in the countries listed below.


Ingredient matches for Weiliufen



Sulfasalazine

Sulfasalazine is reported as an ingredient of Weiliufen in the following countries:


  • China

International Drug Name Search


Seftac




Seftac may be available in the countries listed below.


Ingredient matches for Seftac



Teprenone

Teprenone is reported as an ingredient of Seftac in the following countries:


  • Japan

International Drug Name Search


Nesacaine-MPF


See also: Generic Nesacaine


Nesacaine-MPF is a brand name of chloroprocaine, approved by the FDA in the following formulation(s):


NESACAINE-MPF (chloroprocaine hydrochloride - injectable; injection)



  • Manufacturer: APP PHARMS

    Approval date: May 2, 1996

    Strength(s): 2% [RLD][AP], 3% [RLD][AP]

Has a generic version of Nesacaine-MPF been approved?


Yes. The following products are equivalent to Nesacaine-MPF:


chloroprocaine hydrochloride injectable; injection



  • Manufacturer: BEDFORD

    Approval date: September 9, 1998

    Strength(s): 2% [AP], 3% [AP]


  • Manufacturer: HOSPIRA

    Approval date: April 16, 1982

    Strength(s): 2% [AP], 3% [AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Nesacaine-MPF. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Nesacaine-MPF.

See also...


    Nalgestan




    Nalgestan may be available in the countries listed below.


    Ingredient matches for Nalgestan



    Chlorphenamine

    Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Nalgestan in the following countries:


    • Indonesia

    Phenylpropanolamine

    Phenylpropanolamine hydrochloride (a derivative of Phenylpropanolamine) is reported as an ingredient of Nalgestan in the following countries:


    • Indonesia

    International Drug Name Search


    Healer




    Healer may be available in the countries listed below.


    Ingredient matches for Healer



    Omeprazole

    Omeprazole is reported as an ingredient of Healer in the following countries:


    • Bangladesh

    International Drug Name Search


    Tuesday, October 18, 2016

    Naixan




    Naixan may be available in the countries listed below.


    Ingredient matches for Naixan



    Naproxen

    Naproxen is reported as an ingredient of Naixan in the following countries:


    • Japan

    International Drug Name Search


    Salicil Mix




    Salicil Mix may be available in the countries listed below.


    In some countries, this medicine may only be approved for veterinary use.

    Ingredient matches for Salicil Mix



    Aspirin

    Acetylsalicylic Acid is reported as an ingredient of Salicil Mix in the following countries:


    • Italy

    International Drug Name Search


    Urgocor




    Urgocor may be available in the countries listed below.


    Ingredient matches for Urgocor



    Salicylic Acid

    Salicylic Acid is reported as an ingredient of Urgocor in the following countries:


    • Germany

    International Drug Name Search


    Ornicetil




    Ornicetil may be available in the countries listed below.


    Ingredient matches for Ornicetil



    Ornithine

    Ornithine oxoglurate (a derivative of Ornithine) is reported as an ingredient of Ornicetil in the following countries:


    • Bosnia & Herzegowina

    International Drug Name Search


    Ottogenta




    Ottogenta may be available in the countries listed below.


    Ingredient matches for Ottogenta



    Gentamicin

    Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Ottogenta in the following countries:


    • Indonesia

    International Drug Name Search


    Sinulen




    Sinulen may be available in the countries listed below.


    Ingredient matches for Sinulen



    Oxymetazoline

    Oxymetazoline hydrochloride (a derivative of Oxymetazoline) is reported as an ingredient of Sinulen in the following countries:


    • Israel

    International Drug Name Search


    Monday, October 17, 2016

    Simvastatin acis




    Simvastatin acis may be available in the countries listed below.


    Ingredient matches for Simvastatin acis



    Simvastatin

    Simvastatin is reported as an ingredient of Simvastatin acis in the following countries:


    • Germany

    International Drug Name Search


    Neosoralen




    Neosoralen may be available in the countries listed below.


    Ingredient matches for Neosoralen



    Trioxysalen

    Trioxysalen is reported as an ingredient of Neosoralen in the following countries:


    • India

    International Drug Name Search


    Sidobac




    Sidobac may be available in the countries listed below.


    Ingredient matches for Sidobac



    Ceftazidime

    Ceftazidime is reported as an ingredient of Sidobac in the following countries:


    • Bangladesh

    International Drug Name Search


    Oksabron




    Oksabron may be available in the countries listed below.


    Ingredient matches for Oksabron



    Oxolamine

    Oxolamine phosphate (a derivative of Oxolamine) is reported as an ingredient of Oksabron in the following countries:


    • Turkey

    International Drug Name Search


    Sunday, October 16, 2016

    Doxatrim




    Doxatrim may be available in the countries listed below.


    In some countries, this medicine may only be approved for veterinary use.

    Ingredient matches for Doxatrim



    Sulfadiazine

    Sulfadiazine is reported as an ingredient of Doxatrim in the following countries:


    • Italy

    Trimethoprim

    Trimethoprim is reported as an ingredient of Doxatrim in the following countries:


    • Italy

    International Drug Name Search


    Sulpirid beta




    Sulpirid beta may be available in the countries listed below.


    Ingredient matches for Sulpirid beta



    Sulpiride

    Sulpiride is reported as an ingredient of Sulpirid beta in the following countries:


    • Germany

    International Drug Name Search


    Sedazin




    Sedazin may be available in the countries listed below.


    Ingredient matches for Sedazin



    Lorazepam

    Lorazepam is reported as an ingredient of Sedazin in the following countries:


    • Switzerland

    International Drug Name Search


    Dopamin Sintetica




    Dopamin Sintetica may be available in the countries listed below.


    Ingredient matches for Dopamin Sintetica



    Dopamine

    Dopamine hydrochloride (a derivative of Dopamine) is reported as an ingredient of Dopamin Sintetica in the following countries:


    • Switzerland

    International Drug Name Search


    Novo-Spirozine




    Novo-Spirozine may be available in the countries listed below.


    Ingredient matches for Novo-Spirozine



    Hydrochlorothiazide

    Hydrochlorothiazide is reported as an ingredient of Novo-Spirozine in the following countries:


    • Canada

    Spironolactone

    Spironolactone is reported as an ingredient of Novo-Spirozine in the following countries:


    • Canada

    International Drug Name Search


    Voltarène




    Voltarène may be available in the countries listed below.


    Ingredient matches for Voltarène



    Diclofenac

    Diclofenac is reported as an ingredient of Voltarène in the following countries:


    • Tunisia

    Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Voltarène in the following countries:


    • France

    International Drug Name Search


    Nebulex




    Nebulex may be available in the countries listed below.


    Ingredient matches for Nebulex



    Fluticasone

    Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Nebulex in the following countries:


    • Chile

    International Drug Name Search


    Saturday, October 15, 2016

    Doxycyclin Heumann




    Doxycyclin Heumann may be available in the countries listed below.


    Ingredient matches for Doxycyclin Heumann



    Doxycycline

    Doxycycline monohydrate (a derivative of Doxycycline) is reported as an ingredient of Doxycyclin Heumann in the following countries:


    • Germany

    International Drug Name Search


    NovoMix 30




    NovoMix 30 may be available in the countries listed below.


    UK matches:

    • NovoMix 30 FlexPen 100 U/ml, suspension for injection in a pre-filled pen.
    • NovoMix 30 Penfill 100 U/ml, suspension for injection in cartridge.
    • NovoMix 30 Penfill 100 U/ml, NovoMix 30 FlexPen 100 U/ml (SPC)

    Ingredient matches for NovoMix 30



    Insulin Aspart

    Insulin Aspart is reported as an ingredient of NovoMix 30 in the following countries:


    • United Kingdom

    Insulin Aspart biphasic (a derivative of Insulin Aspart) is reported as an ingredient of NovoMix 30 in the following countries:


    • Bangladesh

    • Canada

    • Greece

    • Switzerland

    International Drug Name Search

    Glossary

    SPC Summary of Product Characteristics (UK)

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Diliter




    Diliter may be available in the countries listed below.


    Ingredient matches for Diliter



    Diltiazem

    Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Diliter in the following countries:


    • Italy

    Duloxetine

    Duloxetine is reported as an ingredient of Diliter in the following countries:


    • Bangladesh

    International Drug Name Search


    Sachet Diet CS




    Sachet Diet CS may be available in the countries listed below.


    In some countries, this medicine may only be approved for veterinary use.

    Ingredient matches for Sachet Diet CS



    Colistin Sulfate

    Colistin sulfate (a derivative of Colistin) is reported as an ingredient of Sachet Diet CS in the following countries:


    • France

    Sulfadimidine

    Sulfadimidine is reported as an ingredient of Sachet Diet CS in the following countries:


    • France

    International Drug Name Search


    Urso Heumann




    Urso Heumann may be available in the countries listed below.


    Ingredient matches for Urso Heumann



    Ursodeoxycholic Acid

    Ursodeoxycholic Acid is reported as an ingredient of Urso Heumann in the following countries:


    • Germany

    International Drug Name Search


    Zirgan




    In the US, Zirgan (ganciclovir ophthalmic) is a member of the drug class ophthalmic anti-infectives and is used to treat Herpes Simplex Dendritic Keratitis.

    US matches:

    • Zirgan

    • Zirgan Gel

    Ingredient matches for Zirgan



    Ganciclovir

    Ganciclovir is reported as an ingredient of Zirgan in the following countries:


    • United States

    International Drug Name Search


    Stavex




    Stavex may be available in the countries listed below.


    Ingredient matches for Stavex



    Stavudine

    Stavudine is reported as an ingredient of Stavex in the following countries:


    • Ethiopia

    International Drug Name Search


    Friday, October 14, 2016

    Neoseptolete




    Neoseptolete may be available in the countries listed below.


    Ingredient matches for Neoseptolete



    Cetylpyridinium

    Cetylpyridinium chloride (a derivative of Cetylpyridinium) is reported as an ingredient of Neoseptolete in the following countries:


    • Slovenia

    International Drug Name Search


    Newtock




    Newtock may be available in the countries listed below.


    Ingredient matches for Newtock



    Formoterol

    Formoterol fumarate (a derivative of Formoterol) is reported as an ingredient of Newtock in the following countries:


    • Vietnam

    International Drug Name Search